Explore the rise of GenAI, its ethical dilemmas, and why enterprises are adopting private AI for better data security, control and compliance in hybrid cloud environments.

Cloud FinOps optimizes cloud spending while integrating sustainability, focusing on efficient, eco-friendly cloud management and aligning costs with green carbon initiatives for a sustainable future.

Harnessing digital power: Smart technologies to supercharge manufacturing processes

To succeed in this evolving market, lenders must balance cost efficiency, exceptional customer experiences and stringent regulatory adherence

Industry cloud solutions are gaining traction as they offer tailored services for specific industries, enabling faster innovation, regulatory compliance and competitive differentiation for businesses.

Large Language Models (LLMs) like OpenAI’s GPT have gained attention but pose challenges. High costs, resource demands and privacy concerns have led to a shift to small language models (SLMs).

The blog explores the critical importance of embedding ethical considerations into AI, calling for transparent governance models and proactive human assessment to empower user privacy.

HCLTech and Intel redefine digital trust, merging Intel’s TDX and Tiber Trust with CloudSMART services for unmatched security in multicloud environments.

The rapid growth of AI, the widespread use of cloud computing and the increasing demand for analytics have introduced new challenges to data security and privacy.

The Internet of Behaviors (IoB), an emerging field that harmonizes behavioral science, edge analytics & the Internet of Things (IoT), is being used to carefully analyze user data and provide insights

HCLTech offers solutions to modernize databases, enhancing efficiency, reducing costs, enabling cloud and open-source adoption, and driving productivity and innovation for businesses.

AI is transforming the life sciences industry by enhancing data integration, addressing ethical concerns, and ensuring secure, compliant AI applications across the pharma value chain.